Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MRSN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MRSN investment potential.

What is MRSN stock price today?

Get real-time MRSN stock price, historical data, and price charts on Financhill. Track MRSN performance with our advanced analysis tools.

Is MRSN a good investment?

Evaluate MRSN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MRSN stock?

To buy MRSN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MRSN?

View detailed market capitalization data and company valuation metrics for MRSN on our comprehensive analysis page.

What is the P/E ratio of MRSN?

Use our fundamental analysis tools to view MRSN P/E ratio and compare valuation metrics with industry peers.

What are MRSN earnings?

View MRSN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Mersana Therapeutics, Inc. 10K Form

Sell

MRSN
Mersana Therapeutics, Inc.

Last Price:

$27.40

Seasonality Move:

20.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-07	10Q	MRSN/Mersana Therapeutics, Inc. Quarterly
2020-05-08	10Q	MRSN/Mersana Therapeutics, Inc. Quarterly
2020-02-28	10K	MRSN/Mersana Therapeutics, Inc. Annual
2019-11-06	10Q	MRSN/Mersana Therapeutics, Inc. Quarterly
2019-08-08	10Q	MRSN/Mersana Therapeutics, Inc. Quarterly
2019-05-09	10Q	MRSN/Mersana Therapeutics, Inc. Quarterly

Receive MRSN News And Ratings

See the #1 stock for the next 7 days that we like better than MRSN

MRSN Financial Statistics

Sales & Book Value

Annual Sales:	$40.5M
Cash Flow:	$-3.2M
Price / Cash Flow:	0
Annual Sales:	$-11.91
Price / Book:	57.95

Profitability

EPS (TTM):	-9.43320
Net Income (TTM):	$-70.1M
Gross Margin:	$38.9M
Return on Equity:	-533.43%
Return on Assets:	-61.05%

Mersana Therapeutics, Inc. Earnings Forecast

Key Mersana Therapeutics, Inc. Financial Ratios

The Gross Profit Margin over the past 10 years for MRSN is 95.98%.
The Selling, General & Administrative Expenses for MRSN have been equal to 100.78% of Gross Profit Margin.
The Research & Development expenses have been 180.31% of Revenue.
The Net Earning history of MRSN is -170.86% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 4 years.

Mersana Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	MRSN
CUSIP:	59045L
Website:	mersana.com

Debt

Debt-to-Equity Ratio:	-0.04
Current Ratio:	1.39
Quick Ratio:	1.32

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

MRSN Technical Analysis vs Fundamental Analysis